Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Observational Study of OCT in a Patients Undergoing FFR

ClinicalTrials.gov ID: NCT01663896

Public ClinicalTrials.gov record NCT01663896. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Observational Study of Optical Coherence Tomography (OCT) in Patients Undergoing Fractional Flow Reserve (FFR) and Percutaneous Coronary Intervention Stage I (ILUMIEN I)

Study identification

NCT ID
NCT01663896
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
418 participants

Conditions and interventions

Interventions

  • OCT stent guidance Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2012
Primary completion
Mar 11, 2015
Completion
Sep 30, 2015
Last update posted
Jul 1, 2020

2012 – 2015

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
University Hospital - Univ. of Alabama at Birmingham (UAB) Birmingham Alabama 35233
Scripps Clinic, Green Hospital La Jolla California
Florida Hospital Orlando Orlando Florida
Emory University Hospital Atlanta Georgia
Loyola University Chicago Maywood Illinois 60153
Central Baptist Hospital Lexington Kentucky
Baptist Health East Louisville Kentucky
St. Luke's Hospital/Mid America Heart Kansas City Missouri
Rutgers Cardiovascular Institute New Brunswick New Jersey
Mount Sinai Medical Center New York New York
Heart Hospital of Austin Austin Texas
Dallas VA Medical Center Dallas Texas
University of Texas Medical Branch at Galveston Galveston Texas
Swedish Medical Center Seattle Washington
Aurora St. Luke's Medical Center Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01663896, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01663896 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →